Unfree market

By Marc Levy

Published: August 3, 2004

The United States is essentially a captive market for drug makers, which sell drugs at dramatically lower costs everywhere else and rely on profits here to make up the difference. We pay the industry’s research and development costs, and a change, drug makers say, would end innovation. So it worries the industry that there’s a [...]

Sweet deal

By Marc Levy

Published: January 25, 2004

As the Parmalat scandal hints, and the World Economic Forum going on in Davos, Switzerland, has just confirmed, European businesses are just as feckless and prone to illegality as U.S. businesses — and just as prone to try to avoid, and end, regulation. Reuters is reporting that business executives at the conference “shunned calls for [...]

The French-Canadian connection

By Marc Levy

Published: October 28, 2003

At last someone’s saying it and, even better, backing it up with a numbers: “The question is really safety, and the fact is … Canadian procedures for safety are comparable and sometimes even better” than those of the United States. The speaker was Illinois Gov. Rod R. Blagojevich, a leader in the effort to import [...]